Spinal Muscular Atrophy

Overview

Spinal muscular atrophy (SMA) is a genetic neuromuscular condition that affects the nerve cells in the spinal cord and brainstem that control voluntary muscle movement. These nerve cells, called motor neurons, send signals to muscles used for activities such as breathing, swallowing, sitting, standing and walking. In SMA, the motor neurons do not work properly and may be lost over time, leading to muscle weakness and reduced muscle bulk.

SMA can affect infants, children, teenagers or adults. The age when symptoms begin and the level of muscle weakness can vary widely. Some babies show signs early in life, while others develop symptoms later and have milder movement difficulties. Although SMA is a lifelong condition, advances in diagnosis, supportive care and disease-modifying treatments have improved care planning and quality of life for many patients.

Symptoms

The symptoms of SMA depend on the type of SMA, the age at onset and the muscles affected. Muscle weakness is usually more noticeable in the muscles closest to the center of the body, such as the shoulders, hips, thighs and upper arms.

• Low muscle tone or “floppiness” in babies
• Delayed motor milestones, such as difficulty holding the head up, sitting, crawling or walking
• Weakness in the arms and legs
• Difficulty standing, climbing stairs or rising from the floor
• Muscle twitching, especially in the tongue or small muscles
• Poor weight gain or feeding difficulties in infants
• Swallowing problems or risk of choking
• Weak cough or frequent chest infections
• Breathing difficulties, especially during sleep or respiratory illnesses
• Curvature of the spine or joint stiffness due to muscle weakness

Intelligence and sensation are typically not affected by SMA. Many people with SMA are alert, interactive and able to learn normally, even when physical movement is limited.

Causes and Risk Factors

SMA is most often caused by changes in a gene that is important for motor neuron survival. When this gene does not produce enough of a necessary protein, motor neurons become unhealthy and muscles receive fewer signals to move.

SMA is usually inherited in an autosomal recessive pattern. This means a child may be affected if they inherit a non-working copy of the gene from both parents. Parents who carry one non-working copy usually do not have symptoms themselves and may not know they are carriers.

The main risk factor is having a family history of SMA or being a carrier of the gene change. However, SMA can also occur in families with no known previous history. Genetic counseling can help families understand inheritance patterns, carrier testing and future pregnancy options.

Diagnosis

Diagnosis begins with a medical history and physical examination, especially when a baby or child has muscle weakness, delayed milestones or breathing and feeding concerns. A neurologist may assess muscle tone, reflexes, strength and movement patterns.

Genetic testing is the key test used to confirm SMA. It can identify the gene changes associated with the condition. In some cases, additional tests may be recommended to understand muscle and nerve function or to evaluate breathing, swallowing and nutrition. These may include blood tests, nerve and muscle studies, sleep or breathing assessments, and imaging of the spine if there are posture or curvature concerns.

Early diagnosis is important because treatment planning, respiratory support, nutrition care, physical therapy and family counseling can begin as soon as possible. In some countries, newborn screening programs may help identify SMA before symptoms become obvious.

Treatment Options

Treatment for SMA is individualized and usually involves a multidisciplinary team. The team may include specialists in neurology, pulmonology, rehabilitation, nutrition, orthopedics, genetics, speech and swallowing therapy, and pediatric or adult care, depending on the patient’s age and needs.

Disease-modifying therapies are available for some patients with SMA. These treatments aim to increase the amount of the protein needed by motor neurons or address the underlying genetic problem. Suitability depends on factors such as age, SMA type, clinical condition and local availability. A specialist can explain the potential benefits, limitations and monitoring requirements.

Supportive care is also central to SMA management. Physical therapy and stretching can help maintain flexibility, posture and comfort. Assistive devices, braces, wheelchairs or standing supports may improve mobility and independence. Respiratory care may include monitoring breathing strength, supporting cough effectiveness and managing chest infections promptly. Nutritional support may be needed when feeding or swallowing is difficult. Orthopedic care may be recommended for spine curvature, hip problems or joint stiffness.

The goal of treatment is to support breathing, nutrition, movement, comfort and participation in daily life. Care plans are reviewed regularly because needs can change over time.

When to See a Doctor

Medical evaluation is important if a baby, child or adult develops unexplained muscle weakness or loss of motor abilities. Parents should seek medical advice if an infant seems unusually floppy, has difficulty feeding, has poor head control, does not reach expected movement milestones or has weak crying or coughing.

Urgent medical attention is needed if there are breathing difficulties, bluish lips, repeated choking, severe swallowing problems, unusual sleepiness, or signs of a chest infection such as persistent cough, fever or increased work of breathing.

Families with a known history of SMA, or couples concerned about carrier status, may benefit from speaking with a genetics professional. Early specialist assessment can help clarify the diagnosis and guide appropriate care and support.